Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes.
S J Lane, … , P J Barnes, T H Lee
S J Lane, … , P J Barnes, T H Lee
Published December 15, 1998
Citation Information: J Clin Invest. 1998;102(12):2156-2164. https://doi.org/10.1172/JCI2680.
View: Text | PDF
Research Article Article has an altmetric score of 9

Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes.

  • Text
  • PDF
Abstract

Unstimulated peripheral blood mononuclear cells (PBMCs) from corticosteroid-resistant (CR) but not corticosteroid-sensitive (CS) asthmatics demonstrate increased activating peptide-1 (AP-1)- and decreased glucocorticoid receptor (GR)-DNA binding. We test whether these abnormalities are associated with excessive generation of c-fos, the inducible component of AP-1. The c-fos transcription rate, mRNA and protein levels, and GR-DNA binding were quantitated in PBMCs, T cells, and monocytes from CS, CR, and nonasthmatic subjects. There was a 1.7-, 4.2-, and 2.3-fold greater increase in the baseline c-fos transcription rate, mRNA expression, and protein levels, respectively, in PBMCs derived from CR compared with CS patients. At optimal stimulation with PMA, there was a 5.7-, 3.4-, and 2-fold greater increase in the c-fos transcription rate, mRNA accumulation, and protein levels, respectively, in CR compared with CS PBMCs. These abnormalities were detected in both the T cell and monocyte subpopulations. PMA stimulation converted PBMCs from a CS to a CR phenotype and was associated with direct interaction between c-Fos and the GR. Pretreatment of PBMCs from CR patients with c-fos antisense oligonucleotides enhanced GR-DNA binding activity in CR PBMCs stimulated with dexamethasone. We suggest that increased c-fos synthesis provides a major mechanism for the increased AP-1- and decreased GR- DNA binding seen in CR asthma.

Authors

S J Lane, I M Adcock, D Richards, C Hawrylowicz, P J Barnes, T H Lee

×

Total citations by year

Year: 2024 2023 2020 2019 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 Total
Citations: 1 2 1 2 3 2 4 3 2 1 5 7 8 1 2 7 11 5 13 9 7 8 3 107
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (107)

Title and authors Publication Year
In Vivo Exposure of Deltamethrin Dysregulates the NFAT Signalling Pathway and Induces Lung Damage.
Sharma P, Sethi RS
Journal of toxicology 2024
Gene expression profiles and bioinformatics analysis in lung samples from ovalbumin-induced asthmatic mice
Song Y, Jiang J, Bai Q, Liu S, Zhang Y, Xu C, Piao H, Li L, Yan G
BMC Pulmonary Medicine 2023
Grandmaternal allergen sensitization reprograms epigenetic and airway responses to allergen in second-generation offspring.
Lebold KM, Cook M, Pincus AB, Nevonen KA, Davis BA, Carbone L, Calco GN, Pierce AB, Proskocil BJ, Fryer AD, Jacoby DB, Drake MG
American journal of physiology. Lung cellular and molecular physiology 2023
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma
C Pelaia, A Vatrella, C Crimi, L Gallelli, R Terracciano, G Pelaia
Expert Review of Respiratory Medicine 2020
Transcriptomics in tissue glucocorticoid sensitivity
NC Nicolaides, A Polyzos, E Koniari, A Lamprokostopoulou, I Papageorgiou, E Golfinopoulou, C Papathanasiou, A Sertedaki, D Thanos, GP Chrousos, E Charmandari
European Journal of Clinical Investigation 2019
Erythromycin reverses cigarette smoke extract-induced corticosteroid insensitivity by inhibition of the JNK/c-Jun pathway
YF Bin, N Ma, YX Lu, XJ Sun, Y Liang, J Bai, JQ Zhang, MH Li, XN Zhong, ZY He
Free radical biology & medicine 2019
Pharmacological targeting of allergen-specific T lymphocytes
PA Tauber, WF Pickl
Immunology Letters 2017
Differential Expression of Serum MicroRNAs Supports CD4+ T Cell Differentiation into Th2/Th17 Cells in Severe Equine Asthma
A Pacholewska, M Kraft, V Gerber, V Jagannathan
Genes & development 2017
Severe Asthma
YC Lee, SR Kim, SH Cho
Severe Asthma 2017
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
PJ Barnes
Pharmacological reviews 2016
Pharmacology and Therapeutics of Asthma and COPD
CP Page, PJ Barnes
Pharmacology and Therapeutics of Asthma and COPD 2016
An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance
DK Ingawale, SK Mandlik, SS Patel
Journal of Complementary and Integrative Medicine 2015
Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation
CR Keenan, D Radojicic, M Li, A Radwan, AG Stewart
Pharmacology & Therapeutics 2015
SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model
HM Wu, L Fang, QY Shen, RY Liu
Molecular Immunology 2015
Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma
BE Himes, C Koziol-White, M Johnson, C Nikolos, W Jester, B Klanderman, AA Litonjua, KG Tantisira, K Truskowski, K MacDonald, RA Panettieri, ST Weiss, RE Morty
PloS one 2015
Pharmacology of intra-articular triamcinolone
J Scherer, KD Rainsford, CA Kean, WF Kean
Inflammopharmacology 2014
Mechanisms of glucocorticoid action and insensitivity in airways disease
C Boardman, L Chachi, A Gavrila, CR Keenan, MM Perry, YC Xia, H Meurs, P Sharma
Pulmonary Pharmacology & Therapeutics 2014
Correlation of c-fos protein expression with neuropeptide content in the lung of bronchial asthmatic rat
Haiyan Liu, Xudong Yang, Wei Hou
International journal of clinical and experimental pathology 2014
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
PJ Barnes
Journal of Allergy and Clinical Immunology 2013
Role of Transcription Factors in the Pathogenesis of Asthma and COPD
G Caramori, P Casolari, I Adcock
Cell communication & adhesion 2013
Glucocorticoid-resistant asthma and novel anti-inflammatory drugs
CR Keenan, S Salem, ER Fietz, RC Gualano, AG Stewart
Drug Discovery Today 2012
Inflammatory Stimuli Inhibit Glucocorticoid-Dependent Transactivation in Human Pulmonary Epithelial Cells: Rescue by Long-Acting β 2 -Adrenoceptor Agonists
CF Rider, EM King, NS Holden, MA Giembycz, R Newton
The Journal of pharmacology and experimental therapeutics 2011
Glucocorticosteroids: current and future directions
PJ Barnes
British Journal of Pharmacology 2011
DHEA in Human Health and Aging
A Genazzani, C Lanzoni
DHEA in Human Health and Aging 2011
Comparative Analysis of Steroid Sensitivity of T Helper Cells in vitro and in vivo
A Abe, T Ohtomo, S Koyama, N Kitamura, O Kaminuma, A Mori
International Archives of Allergy and Immunology 2011
Asma de control difícil: factores predisponentes y factores agravantes
MG Martín, CM Moreno, AL Viña, CC Serrano, JJ Esteban
Revista de Patología Respiratoria 2011
Mechanisms and resistance in glucocorticoid control of inflammation
PJ Barnes
The Journal of Steroid Biochemistry and Molecular Biology 2010
Apolipoprotein E Negatively Regulates House Dust Mite–induced Asthma via a Low-Density Lipoprotein Receptor–mediated Pathway
X Yao, K Fredriksson, ZX Yu, X Xu, N Raghavachari, KJ Keeran, GJ Zywicke, M Kwak, MJ Amar, AT Remaley, SJ Levine
American journal of respiratory and critical care medicine 2010
Corticosteroid insensitivity in severe asthma: significance, mechanisms and aetiology
M Hew, KF Chung
Internal Medicine Journal 2010
Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases
R Newton, R Leigh, MA Giembycz
Pharmacology & Therapeutics 2010
Pharmacogenomics in the treatment of inflammatory bowel disease
MA Smith, AM Marinaki, JD Sanderson
Pharmacogenomics 2010
Pharmacogenomics of pediatric asthma
S Gupta, S Awasthi
Indian journal of human genetics 2010
Allergy Frontiers: Future Perspectives
R Pawankar, ST Holgate, LJ Rosenwasser
2010
Crosstalk in Inflammation: The Interplay of Glucocorticoid Receptor-Based Mechanisms and Kinases and Phosphatases
IM Beck, WV Berghe, L Vermeulen, KR Yamamoto, G Haegeman, KD Bosscher
Endocrine reviews 2009
Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future
KF Chung, G Caramori, IM Adcock
European Journal of Clinical Pharmacology 2009
Glucocorticoid resistance in inflammatory diseases
PJ Barnes, IM Adcock
The Lancet 2009
Asthma phenotypes in adults and clinical implications
ML Fajt, SE Wenzel
Expert Review of Respiratory Medicine 2009
Enhancement of ligand-dependent down-regulation of glucocorticoid receptor by lipopolysaccharide
N Hirasawa, K Yashima, K Ishihara
Life Sciences 2009
Asthma and COPD
SA Shore, SD Shapiro
Asthma and COPD 2009
Transcription Factors
IM Adcock, G Caramori
Asthma and COPD 2009
Allergy Frontiers: Therapy and Prevention
R Pawankar, ST Holgate, LJ Rosenwasser
2009
New drugs targeting Th2 lymphocytes in asthma
G Caramori, D Groneberg, K Ito, P Casolari, IM Adcock, A Papi
Journal of occupational medicine and toxicology (London, England) 2008
Clinical and molecular aspects of glucocorticoid resistant asthma
CJ Corrigan, TK Loke
Therapeutics and Clinical Risk Management 2007
Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine
T Hirano
International Immunopharmacology 2007
Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII
R Donn, A Berry, A Stevens, S Farrow, J Betts, R Stevens, C Clayton, J Wang, L Warnock, J Worthington, L Scott, S Graham, D Ray
The FASEB Journal 2006
Variable therapeutic response in asthma: a genetic perspective
P Bhatnagar, R Guleria, R Kukreti
Personalized Medicine 2006
Update on glucocorticoid action and resistance
K Ito, KF Chung, IM Adcock
Journal of Allergy and Clinical Immunology 2006
Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFα in human epidermal keratinocytes (HaCaT)
K Onda, M Nagashima, Y Kawakubo, S Inoue, T Hirano, K Oka
Biochemical and Biophysical Research Communications 2006
Asthma: defining of the persistent adult phenotypes
SE Wenzel
The Lancet 2006
Physiologic and Pathologic Abnormalities in Severe Asthma
S Wenzel
Clinics in Chest Medicine 2006
Handbook of Atopic Eczema
J Ring, B Przybilla, T Ruzicka
2006
Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology
A Gladkevich, SA Nelemans, HF Kauffman, J Korf
Mediators of Inflammation 2005
Glucocorticoid Action and Resistance in Asthma
CJ Corrigan, TH Lee
Allergology International 2005
Mecanismos moleculares de los glucocorticoides
BG Cosío, A Torrego, IM Adcock
Archivos de Bronconeumología 2005
NeuroImmune Biology
R Solana, G Pawelec
NeuroImmune Biology 2005
Asthme corticorésistant et corticodépendant : quelles solutions ?
KF Chung
Revue Française d'Allergologie et d'Immunologie Clinique 2005
Lung Biology in Health and Disease: Cellular and Molecular Mechanisms
E Sapey, R Stockley
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 2005
Severe Asthma in Adults
S Wenzel
American journal of respiratory and critical care medicine 2005
Molecular Mechanisms of Glucocorticoids
BG Cosío, A Torrego, IM Adcock
Archivos de Bronconeumología (English Edition) 2005
Guidelines for the Diagnosis and Management of Difficult-to-Control Asthma
A López-Viña, R Agüero-Balbín, JL Aller-Álvarez, T Bazús-González, FB García-Cosio, A Diego-Damiá, E Martínez-Moragón, A Pereira-Vega, V Plaza-Moral, G Rodríguez-Trigo, JR Villa-Asensi
Archivos de Bronconeumología (English Edition) 2005
The Search for Safer Glucocorticoid Receptor Ligands
J Rosen, JN Miner
Endocrine reviews 2005
Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice
, J Schölmerich, C Gasché, B Vucelic
2005
Glucocorticoid-resistant asthma
CJ Corrigan, CM Hawrylowicz, P Lavender, TH Lee
Clinical & Experimental Allergy Reviews 2004
Systemic Inflammation-Associated Glucocorticoid Resistance and Outcome of ARDS
GU Meduri, CR Yates
Annals of the New York Academy of Sciences 2004
Effects of glucocorticoids on gene transcription
R Hayashi, H Wada, K Ito, IM Adcock
European Journal of Pharmacology 2004
Corticosteroids: the mainstay in asthma therapy
R Gupta, DP Jindal, G Kumar
Bioorganic & Medicinal Chemistry 2004
Potential genetic influences on the response to asthma treatment
G Pelaia, A Vatrella, L Gallelli, M Cazzola, R Maselli, SA Marsico
Pulmonary Pharmacology & Therapeutics 2004
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
KD Bosscher, WV Berghe, G Haegeman
Endocrine reviews 2003
Aldehydes mediate tissue factor induction: A possible mechanism linking lipid peroxidation to thrombotic events
A Cabr�, J Girona, JC Vallv�, L Masana
Journal of Cellular Physiology 2003
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases
G Pelaia, A Vatrella, G Cuda, R Maselli, SA Marsico
Life Sciences 2003
Histamine Enhances the Production of Nerve Growth Factor in Human Keratinocytes
N Kanda, S Watanabe
Journal of Investigative Dermatology 2003
13th European Respiratory Society Annual Congress
L Tsaprouni, IM Adcock
Expert Opinion on Investigational Drugs 2003
Pathology of difficult asthma
S Wenzel
Paediatric Respiratory Reviews 2003
17beta-Estradiol Enhances the Production of Nerve Growth Factor in THP-1-Derived Macrophages or Peripheral Blood Monocyte-Derived Macrophages
N Kanda, S Watanabe
Journal of Investigative Dermatology 2003
Mechanisms of severe asthma
S Wenzel
Clinical & Experimental Allergy 2003
Therapeutic opportunities for antagonism of macrophage migration inhibitory factor
EF Morand, M Leech, MN Iskander
Expert Opinion on Therapeutic Patents 2003
Lung Biology in Health and Disease
N Zamel
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 2003
Personalised prescribing for asthma - is pharmacogenetics the answer?
JC Dewar, IP Hall
Journal of Pharmacy and Pharmacology 2003
Severe/Fatal Asthma
S Wenzel
Chest 2003
Inflammatory Bowel Disease: From Bench to Bedside
SR Targan, F Shanahan, LC Karp
2003
Glucocorticoid-resistant asthma
TK Loke, AR Sousa, CJ Corrigan, TH Lee
Current Allergy and Asthma Reports 2002
Effects of Tachykinins and Histamine on the Expression of Thymus- and Activation-Regulated Chemokine mRNA in Peripheral Blood Mononuclear Cells and Human Bronchial Epithelial Cells
T Negoro, K Takekawa, K Satoh, Y Nakano, K Kasahara, T Ozawa, Y Iikura, M Adachi, T Tobe
JOURNAL OF HEALTH SCIENCE 2002
Expression of mRNA for glucocorticoid receptors in peripheral blood mononuclear cells of patients with Crohn's disease
T Hori, K Watanabe, M Miyaoka, F Moriyasu, K Onda, T Hirano, K Oka
Journal of Gastroenterology and Hepatology 2002
Expression of c-fos, rather than c-jun or glucocorticoid-receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma
E Takahashi, K Onda, T Hirano, K Oka, N Maruoka, M Tsuyuguchi, Y Matsumura, T Niitsuma, T Hayashi
International Immunopharmacology 2002
Refractory asthma
M McGeehan, WW Busse
Medical Clinics of North America 2002
The role of transcription factors in allergic inflammation
L Escoubet-Lozach, CK Glass, SI Wasserman
Journal of Allergy and Clinical Immunology 2002
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
J Galon, D Franchimont, N Hiroi, G Frey, A Boettner, M Ehrhart-Bornstein, JJ Oshea, GP Chrousos, SR Bornstein
The FASEB Journal 2002
Recent Advances in Glucocorticoid Receptor Action
AC Cato, H Schäcke, K Asadullah
2002
Critical role of nuclear factor‐κB and stress‐activated protein kinases in steroid unresponsiveness
H Bantel, ML Schmitz, A Raible, M Gregor, K SchulzeOsthoff
The FASEB Journal 2002
Molecular mechanisms of corticosteroids in all_ergic diseases
PJ Barnes
Allergy 2001
Epithelial cells and atopic diseases
G Girolomoni, S Pastore
Current Allergy and Asthma Reports 2001
Molecular mechanisms of corticosteroid actions
DN Payne, I Adcock
Paediatric Respiratory Reviews 2001
Cross-talk between pro-inflammatory transcription factors and glucocorticoids
IM Adcock, G Caramori
Immunology and Cell Biology 2001
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells† †Abbreviations: AP-1, activator protein-1; Dex, dexamethasone; ERK, extracellular signal-regulated kinases; GCS, glucocorticosteroids; GR, glucocorticoid receptors; H2O2, hydrogen peroxide; HMVEC-L, human microvascular endothelial cells from lung; IL-1β, interleukin-1β; JNK, c-jun N-terminal kinases; MAPK, mitogen-activated protein kinases; Test testosterone; and TNF-α, tumour necrosis factor-α
G Pelaia, G Cuda, A Vatrella, RD Grembiale, GD Sarro, R Maselli, FS Costanzo, VE Avvedimento, D Rotiroti, SA Marsico
Biochemical Pharmacology 2001
Glucocorticoid-regulated Transcription Factors
IM Adcock
Pulmonary Pharmacology & Therapeutics 2001
Lung Biology in Health and Disease: Pathogenesis and Clinical Management
R Ballard
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 2001
Current understanding and problems of steroid- resistant asthma
A Mori
Allergology International 2000
Dysregulated Activation of Activator Protein 1 in Keratinocytes of Atopic Dermatitis Patients with Enhanced Expression of Granulocyte/Macrophage-Colony Stimulating Factor
S Pastore, ML Giustizieri, F Mascia, A Giannetti, K Kaushansky, G Girolomoni
Journal of Investigative Dermatology 2000
Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease-do we have reliable markers?
CM Gelbmann
Inflammatory Bowel Diseases 2000
Presentation at the National Asthma Campaign International Congress, June 1999Controlling the inflammatory response through transcriptional mechanisms
P Lavender, D Cousins, P Smith, T Lee
Clinical & Experimental Allergy 2000
Molecular Mechanisms of Glucocorticosteroid Actions
IM Adcock
Pulmonary Pharmacology & Therapeutics 2000
Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform
AR Sousa, SJ Lane, JA Cidlowski, DZ Staynov, TH Lee
Journal of Allergy and Clinical Immunology 2000
Transcriptional potencies of inhaled glucocorticoids
D Jaffuel, P Demoly, C Gougat, P Balaguer, G Mautino, P Godard, J Bousquet, M Mathieu
American journal of respiratory and critical care medicine 2000
Prediction of Treatment Refractoriness in Ulcerative Colitis and Crohnʼs Disease—Do We Have Reliable Markers?:
CM Gelbmann
Inflammatory Bowel Diseases 2000
In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation
AR Sousa, SJ Lane, C Soh, TH Lee
Journal of Allergy and Clinical Immunology 1999
The importance of being receptive
CJ Heijnen, A Kavelaars
Journal of Neuroimmunology 1999
CORTICOSTEROID-INSENSITIVE ASTHMA
DY Leung, SJ Szefler
Immunology and Allergy Clinics of North America 1999

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 3 Wikipedia pages
Referenced in 1 clinical guideline sources
42 readers on Mendeley
See more details